KYORIN Pharmaceutical Co.,Ltd. [4569.T]
TOKYO, May 12 (Pulse News Wire) – Kyorin Pharmaceutical Co., Ltd. (4569.T) reported consolidated results for fiscal year 2026 ending March.
Revenue was ¥130 billion (-2.9% YoY). operating profit was ¥3,567 million (-71.6%). net profit attributable to shareholders was ¥3,448 million (-62.0%).
Total assets stood at ¥200 billion with an equity ratio of 72.9%. The company declared an annual dividend of ¥37 per share. The full-year forecast for the current fiscal year is revenue of ¥57.8 billion.
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥126,257M | -2.9% |
| Operating profit | ¥3,567M | -71.6% |
| Net profit | ¥3,448M | -62.0% |
Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.